Chain Drug Review - Cymbalta contract
Eli Lilly and Co. and Boehringer Ingelheim GmbH have agreed to commercialize Cymbalta for the treatment of depression in countries outside the United States (excluding Japan). Lilly anticipates that it will make a European submission for the product this year.
Related Results
Cymbalta approvalCymbalta launch expectedCymbalta for GAD, Humira for Crohn’sCymbalta Approved for FibromyalgiaLilly prepares for Cymbalta launch
COPYRIGHT 2003 Racher Press, Inc.
COPYRIGHT 2008 Gale, Cengage Learning
